Latest Canada News

Terra Critical Minerals (ASX, T92) broadens its critical minerals portfolio with new US initiatives and promising exploration in New South Wales and Canada. The company also pursues a US OTC listing to tap North American capital.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Energy Transition Minerals Ltd has acquired the Penouta tin-tantalum-niobium mine in Spain at a significant discount, raised A$18 million in capital, and received a key arbitration ruling on its Greenland rare earths project.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug candidate NUZ-001 and strengthened its balance sheet with a $5.2 million capital raise. The company is now poised to enter the pivotal HEALEY ALS Platform Trial, marking a significant step forward in its neurodegenerative disease program.

Midas Minerals has secured unconditional approval from Namibia’s Competition Commission, paving the way to complete its acquisition of the Otavi Copper Project and launch an aggressive drilling campaign.

Fin Resources Limited has acquired a 100% interest in the drill-ready Cabin Lake Gold Project in Canada’s Northwest Territories, backed by a recent A$1.5 million capital raise to accelerate exploration activities.

Bryah Resources has secured the Golden Pike gold and antimony project in Canada, appointed Greg Hill as CEO, and raised nearly $2 million to fund upcoming drilling and resource upgrades.

NewPeak Metals has completed acquisition of 100% ownership of the Las Opeñas exploration permits in Argentina, with drilling scheduled for early 2026. The company also advances drilling preparations at its Tansey Gold Project in Australia, supported by strong insider buying.

Tasman Resources has progressed its exploration efforts at Lake Torrens and Parkinson Dam projects, backed by a recent $850,000 capital raise and strategic board changes.

Prairie Lithium has fast-tracked its flagship Saskatchewan lithium project by initiating fabrication of a commercial-scale extraction unit and securing vital rail access, supported by a US$5 million non-dilutive capital raise and a promising offtake agreement.

PainChek Ltd has achieved a pivotal FDA De Novo clearance for its AI-driven Adult pain assessment app, unlocking the US market and driving its annual recurring revenue to $5.6 million. The company also launched its Infant app, targeting a vast global market of pre-verbal children.

PainChek has secured FDA De Novo clearance for its Adult App, opening immediate access to a $175 million AUD US long-term care market and advancing its Infant App commercialization targeting a $15 billion AUD global opportunity.